We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Radiofrequency Ablation Effective in Reducing Pain from Bone Metastases

By HospiMedica International staff writers
Posted on 20 Jan 2010
A new study reports that image-guided radiofrequency ablation (RFA) significantly reduced the level of pain experienced by cancer patients with osseous metastases, limiting the need for strong narcotic pain management.

Researchers at Rhode Island Hospital (RIH; Providence, USA) and Brown University (Providence, RI, USA) studied 55 patients who had a single painful bone metastasis. More...
Each patient received computed tomography (CT) guided RFA of the bone metastasis to temperatures of over 60 degrees centigrade. Endpoints were the toxicity and pain effects of RFA pain prior to treatment, daily for two weeks following the procedure, and again at one month and three months after RFA. In all, 55 patients completed RFA.

The results showed that RFA reduced pain at 1 and 3 months for all pain assessment measures. The average increase in pain relief from pre-RFA to 1-month follow-up was 26.3 on a 1-100 scale, and the increase from pre-RFA to 3-month follow-up was 16. The average decrease in pain intensity from pre-RFA to 1-month follow-up was 26.9 and 14.2 for 3-month follow-up. Statistically significant pain reduction was evident in follow-ups for all pain assessment measurements: pain relief, intensity, and severity. In all cases, improvement was seen for each measurement, including patient mood, with the most improvement at the one-month interval. The study was published online ahead of print on December 29, 2009, in the journal Cancer.

"RFA is widely available, covered by most insurance, can be performed in a single outpatient session and often allows patients enhanced interaction with loved ones by reducing use of strong narcotics which can leave them in a medicated state,” said lead author Damian Dupuy, M.D, director of ablation services at RIH. "Also, unlike many other cancer pain management treatments, RFA can be repeated and maintain similar results.”

"Despite advances in radiation technology and development of new medical manipulations, too many cancer patients still experience pain associated with their disease,” said coauthor Thomas DiPetrillo, M.D., an associate professor of radiation oncology at Brown University. "This study demonstrates the palliative benefits of RFA with minimal treatment-related morbidity. Oncologists have another tool for the management of cancer pain.”

Related Links:

Rhode Island Hospital
Brown University




Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.